Home Products Careers

Home ProductsRecombinant Escherichia coli O157:H7 Phosphoribosylamine--glycine ligase (purD)

Recombinant Escherichia coli O157:H7 Phosphoribosylamine--glycine ligase (purD)

Recombinant Escherichia coli O157:H7 Phosphoribosylamine--glycine ligase (purD) thumbnail 1

GTR04825962

Recombinant Escherichia coli O157:H7 Phosphoribosylamine--glycine ligase (purD)

factor-antibody-stimulating

Supplier ID: 399

$311.90($412.49)

Size: 20 µg

Available Sizes

The Academy of Cancer Immunology is at the forefront of advancing our understanding of the critical role immunity plays in cancer treatment and prevention. Founded in 1998 with a generous gift from the Cancer Research Institute (CRI), the Academy brings together the brightest minds from across the globe to explore innovative cancer immunology approaches.

Pages

Home
Products
Careers
Withdrew Requests Form

[email protected] +1(408)472-293460

© 2026 Academy of Cancer Immunology. All rights reserved.